Skip to content
10-K

Annual Report

Pulmonx Corp LUNG

0001127537-26-000015

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 3, 2026 42.24M sh
Shares Diluted FY 2025 · Dec 31, 2025 40.69M sh
Shares Diluted FY 2025 · Dec 31, 2024 39.11M sh
Capex FY 2025 · Dec 31, 2025 $452K
Capex FY 2025 · Dec 31, 2024 $1.45M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$32.38M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$31.54M
Long Term Debt FY 2025 · Dec 31, 2025 $36.99M
Long Term Debt FY 2025 · Dec 31, 2024 $34M
Short Term Debt FY 2025 · Dec 31, 2025 $106K
Short Term Debt FY 2025 · Dec 31, 2024 $3.18M
Cash And Equivalents FY 2025 · Dec 31, 2025 $69.75M
Cash And Equivalents FY 2025 · Dec 31, 2024 $70.91M
Stockholders Equity FY 2025 · Dec 31, 2025 $54.12M
Stockholders Equity FY 2025 · Dec 31, 2024 $85.81M
Stockholders Equity FY 2025 · Dec 31, 2023 $118.32M
Current Liabilities FY 2025 · Dec 31, 2025 $20.06M
Current Liabilities FY 2025 · Dec 31, 2024 $24.44M
Total Liabilities FY 2025 · Dec 31, 2025 $75.18M
Total Liabilities FY 2025 · Dec 31, 2024 $77.04M
Current Assets FY 2025 · Dec 31, 2025 $101.68M
Current Assets FY 2025 · Dec 31, 2024 $136.25M
Total Assets FY 2025 · Dec 31, 2025 $129.29M
Total Assets FY 2025 · Dec 31, 2024 $162.85M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.33
Eps Diluted FY 2025 · Dec 31, 2024 −$1.44
Eps Basic FY 2025 · Dec 31, 2025 −$1.33
Eps Basic FY 2025 · Dec 31, 2024 −$1.44
Sga Expense FY 2025 · Dec 31, 2025 $101.31M
Sga Expense FY 2025 · Dec 31, 2024 $102.14M
Rd Expense FY 2025 · Dec 31, 2025 $19.49M
Rd Expense FY 2025 · Dec 31, 2024 $17.57M
Net Income FY 2025 · Dec 31, 2025 −$54M
Net Income FY 2025 · Dec 31, 2024 −$56.39M
Operating Income FY 2025 · Dec 31, 2025 −$53.66M
Operating Income FY 2025 · Dec 31, 2024 −$57.7M
Gross Profit FY 2025 · Dec 31, 2025 $67.14M
Gross Profit FY 2025 · Dec 31, 2024 $62M
Cost Of Revenue FY 2025 · Dec 31, 2025 $23.36M
Cost Of Revenue FY 2025 · Dec 31, 2024 $21.79M
Revenue FY 2025 · Dec 31, 2025 $90.5M
Revenue FY 2025 · Dec 31, 2024 $83.79M